SEC
RMD icon

Seven Eight Capital’s ResMed RMD Stock Holding History

Seven Eight Capital’s Portfolio RMD Stock Details RMD Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2024
Q1 		– Sell
-4,696
Closed -$808K – 780
2023
Q4 		$808K Sell
4,696
-61,238
-93% -$9.41M 0.09% 310
2023
Q3 		$9.75M Buy
65,934
+39,999
+154% +$7.23M 1.14% 9
2023
Q2 		$5.67M Buy
+25,935
New +$5.78M 0.94% 11
2023
Q1 		– Sell
-19,436
Closed -$4.05M – 583
2022
Q4 		$4.05M Buy
19,436
+18,171
+1,436% +$3.99M 1.06% 12
2022
Q3 		$276K Buy
1,265
+46
+4% +$10.5K 0.06% 399
2022
Q2 		$256K Buy
+1,219
New +$260K 0.1% 283
2021
Q4 		– Sell
-919
Closed -$242K – 641
2021
Q3 		$242K Buy
+919
New +$251K 0.02% 520
2020
Q4 		– Sell
-3,419
Closed -$586K – 592
2020
Q3 		$586K Buy
+3,419
New +$631K 0.13% 312
2016
Q2 		– Sell
-10,486
Closed -$606K – 648
2016
Q1 		$606K Buy
+10,486
New +$594K 0.26% 127
2015
Q2 		– Sell
-1,301
Closed -$93K – 641
2015
Q1 		$93K Buy
1,301
+500
+62% +$32.5K 0.16% 210
2014
Q4 		$45K Buy
+801
New +$41.8K 0.07% 276
2014
Q1 		– Sell
-1,250
Closed -$59K – 463
2013
Q4 		$59K Buy
+1,250
New +$63.3K 0.07% 379

Other funds holding RMD

Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Bank of New York Mellon
Bank of New York Mellon New York $544B AUM 28.31% 1-Year Est. Return
Geode Capital Management
Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return
Morgan Stanley
Morgan Stanley New York $1.66T AUM 25.57% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
Norges Bank
Norges Bank Oslo, Norway $935B AUM
Northern Trust
Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

Seven Eight Capital's RMD Position: Q1 2024 in Review

Seven Eight Capital sold out of ResMed (RMD) in Q1 2024, closing a stake of 4,696 shares — an estimated $808K sold.

Seven Eight Capital first reported a position in RMD in Q4 2013 and held it in 12 quarters. The position peaked at $9.75M in Q3 2023. 719 funds tracked by Wall St. Rank hold RMD as of Q1 2024.

  • Seven Eight Capital reported no remaining ResMed position as of Q1 2024 after selling out during the quarter.
  • Seven Eight Capital sold 4,696 ResMed shares in Q1 2024, an estimated $808K.
  • Seven Eight Capital first reported a position in ResMed in Q4 2013 and held it in 12 quarters.
  • Seven Eight Capital's ResMed position peaked at $9.75M in Q3 2023.
  • 719 funds tracked by Wall St. Rank held ResMed as of Q1 2024.

Based on Seven Eight Capital's 13F filing for Q1 2024, filed 13 May 2024.